Found: 13
Select item for more details and to access through your institution.
Neoadjuvant therapy of BRCA1-driven ovarian cancer by combination of cisplatin, mitomycin C and doxorubicin.
- Published in:
- Hereditary Cancer in Clinical Practice, 2021, v. 19, n. 1, p. 1, doi. 10.1186/s13053-021-00173-2
- By:
- Publication type:
- Article
Frequency and spectrum of founder and non-founder BRCA1 and BRCA2 mutations in a large series of Russian breast cancer and ovarian cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 184, n. 1, p. 229, doi. 10.1007/s10549-020-05827-8
- By:
- Publication type:
- Article
Detection of BRCA1 gross rearrangements by droplet digital PCR.
- Published in:
- 2017
- By:
- Publication type:
- Report
Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN/NBS1, and BLM germ-line mutations.
- Published in:
- 2014
- By:
- Publication type:
- Report
Molecular predictors of the outcome of paclitaxel plus carboplatin neoadjuvant therapy in high-grade serous ovarian cancer patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 3, p. 439, doi. 10.1007/s00280-021-04301-6
- By:
- Publication type:
- Article
Origin of Residual Tumor Masses in BRCA1/2-Driven Ovarian Carcinomas Treated by Neoadjuvant Chemotherapy: Selection of Preexisting BRCA1/2-Proficient Tumor Cells but Not the Gain of Second ORF-Restoring Mutation.
- Published in:
- Pathobiology, 2024, v. 91, n. 2, p. 108, doi. 10.1159/000533591
- By:
- Publication type:
- Article
Gastric Cancer in BRCA1 Germline Mutation Carriers: Results of Endoscopic Screening and Molecular Analysis of Tumor Tissues.
- Published in:
- Pathobiology, 2020, v. 87, n. 6, p. 367, doi. 10.1159/000511323
- By:
- Publication type:
- Article
Molecular profiles of BRCA1‐associated ovarian cancer treated by platinum‐based therapy: Analysis of primary, residual and relapsed tumors.
- Published in:
- International Journal of Cancer, 2020, v. 146, n. 7, p. 1879, doi. 10.1002/ijc.32776
- By:
- Publication type:
- Article
High prevalence and breast cancer predisposing role of the BLM c.1642 C>T (Q548X) mutation in Russia.
- Published in:
- International Journal of Cancer, 2012, v. 130, n. 12, p. 2867, doi. 10.1002/ijc.26342
- By:
- Publication type:
- Article
Prevalence of the BLM nonsense mutation, p.Q548X, in ovarian cancer patients from Central and Eastern Europe.
- Published in:
- Familial Cancer, 2015, v. 14, n. 1, p. 145, doi. 10.1007/s10689-014-9748-x
- By:
- Publication type:
- Article
Value of bilateral breast cancer for identification of rare recessive at-risk alleles: evidence for the role of homozygous GEN1 c.2515_2519delAAGTT mutation.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Evidence for clinical efficacy of mitomycin C in heavily pretreated ovarian cancer patients carrying germ-line BRCA1 mutation.
- Published in:
- Medical Oncology, 2014, v. 31, n. 10, p. 1, doi. 10.1007/s12032-014-0199-x
- By:
- Publication type:
- Article
Pattern of clinically relevant mutations in consecutive series of Russian colorectal cancer patients.
- Published in:
- Medical Oncology, 2013, v. 30, n. 3, p. 1, doi. 10.1007/s12032-013-0686-5
- By:
- Publication type:
- Article